论文信息 - A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis - 字舞流文

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

C. Goss | H. Rodgers | P. Burgel | J. Nick | M. Salvatore | G. Wesseling | R. Ruseckaite | S. Ahern | J. Dubus | M. Reynaud‐Gaubert | S. Bell | I. Sermet-Gaudelus | S. Rizvi | K. Southern | G. Mujtaba | P. Wark | V. Gulmans | J. Duckers | A. Faro | G. Brinchault | B. Marshall | D. Grenet | H. Corvol | N. Simmonds | G. Daneau | S. Carr | M. Allenby | B. Plant | S. Madge | V. Boussaud | Stephanie Y Cheng | A. Jackson | A. Maitra | A. Stephenson | K. Brownlee | R. Padoan | R. Cosgriff | A. Elbert | P. Middleton | B. Luijk | C. Gunaratnam | R. Ketchell | L. Nährlich | R. Kanaan | C. Byrnes | E. Gunn | Clémence Martin | M. Berdella | A. Prevotat | A. Jones | N. Shafi | K. McBennett | E. McKone | M. Mittaine | Danie Watson | K. D. W. Groot | D. Reid | A. Tatopoulos | Emmanuelle Coirier-Duet | S. D. Miranda | L. Beaumont | Muriel Lauraens | J. Séguin | J. Garbarz | Kristen Rosamilia | R. Belkin | D. Gilmore | K. W. Groot | S. Bell

[1] P. Burgel,et al. Impact of COVID-19 on people with cystic fibrosis , 2020, The Lancet Respiratory Medicine.

[2] D. Halpin,et al. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? , 2020, The Lancet Respiratory Medicine.

[3] C. Whittaker,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.

[4] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.

[5] Dasheng Li,et al. False-Negative Results of Real-Time Reverse-Transcriptase Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2: Role of Deep-Learning-Based CT Diagnosis and Insights from Two Cases , 2020, Korean journal of radiology.

[6] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[7] Ting Yu,et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[8] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[9] C. Teneback,et al. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial , 2019, The Lancet.

[10] E. Kerem,et al. Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[11] A. Hawkins. Cystic Fibrosis Trust , 2009 .

[12] Ben Birkman,et al. The Cystic Fibrosis Foundation , 2017 .